Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season

Clinical trial NCT00316264 · COMPLETED

Trial details

NCT number: NCT00316264
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections Chronic Lung Disease and <= 24 Months of Age or Premature With Gestational Age <=35 Weeks and <=6 Months of Age

Start date: 2006-04-01
Primary completion: 2007-02-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.